Exelixis, Inc. (EXEL)

44.04 -0.11 (-0.25%) USD  |  NASDAQ  |  Jan 09, 16:00
41.85 -2.19 (-4.97%) After-Hours: 07:43
More

Exelixis Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Natera, Inc. Upgrade
Merck & Co., Inc. Upgrade